Astena Holdings (8095) Fundamentals 2026 — P/E 9.0x, Revenue Analysis | SniperIQ
Astena Holdings (8095) is a JP-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥20.8B, trading at ¥515.00 on the JPX. This SniperIQ fundamentals page covers Astena Holdings's valuation (P/E 9.0x, P/B 0.7x), profitability (net margin 3.4%), revenue (¥62.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Astena Holdings's market cap?
Astena Holdings (8095) has a market capitalization of approximately ¥20.8B, trading at ¥515.00 on the JPX. Market cap moves with the live share price.
What is Astena Holdings's P/E ratio?
Astena Holdings's trailing twelve-month P/E ratio is 9.0x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Astena Holdings?
Astena Holdings runs a net profit margin of 3.4%, a gross margin of 34.3%, and an operating margin of 4.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Astena Holdings generate?
Astena Holdings reported revenue of ¥62.7B for fiscal year 2025, with net income of ¥2.2B and earnings per share (EPS) of 54.23. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Astena Holdings pay a dividend?
Astena Holdings offers a trailing dividend yield of about 3.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Astena Holdings financially healthy?
Astena Holdings carries a debt-to-equity ratio of 0.71x and a current ratio of 1.51x, with a market beta of -0.05. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Astena Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Astena Holdings (8095) the key facts are: market cap ¥20.8B, P/E 9.0x, revenue ¥62.7B, 52-week range 456-541. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Astena Holdings's full fundamentals live
Get Astena Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.